Lithuania's BSV Ventures invests in Dutch biotech startup QurieGen

Lithuanian fund BSV Ventures has participated in a €2.2M pre-seed funding round for the Netherlands-based biotech startup QurieGen. Czech investment companies Tensor Ventures (lead), Lighthouse Ventures, Moondust Ventures, 22 Hor Invest, and Tim Draper also participated in the financing.

QurieGen is a startup founded by Dr. Eng. Kinga Matula in 2022 in the Netherlands. The company is building what it calls a “Google Maps for cells” — a tool that helps scientists understand how diseases work and how cancer drugs affect individual cells. QurieGen plans to use the proceeds to accelerate AI-assisted cancer drug development.

BSV Ventures (formerly Baltic Sandbox Ventures) is a venture capital fund specializing in investments in high technology, biotechnology and dual-use technologies in the Baltic States and the rest of Europe. The fund was founded by Sandra Golbreich, Andrius Milinavičius and Erik Bhullar in 2022 in Lithuania. Last year fund has raised $15M from NATO Innovation Fund (NIF), Lithuanian ILTE fund (ex-Invega). BSV Ventures has offices in Lithuania, Estonia and Finland.